Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DG8

Cryo-EM Structure of HPIV3 prefusion F trimer in complex with 3x1 Fab

8DG8 の概要
エントリーDOI10.2210/pdb8dg8/pdb
EMDBエントリー27418
分子名称Fusion glycoprotein F0, 3x1 monoclonal antibody, VH region, 3x1 monoclonal antibody, VL region, ... (4 entities in total)
機能のキーワードcross-neutralizing, hpiv1, hpiv3, mab, immune system
由来する生物種Human parainfluenza 3 virus (strain NIH 47885)
詳細
タンパク質・核酸の鎖数5
化学式量合計192478.27
構造登録者
Rodarte, J.V.,Pancera, M. (登録日: 2022-06-23, 公開日: 2023-02-22, 最終更新日: 2024-11-20)
主引用文献Caban, M.,Rodarte, J.V.,Bibby, M.,Gray, M.D.,Taylor, J.J.,Pancera, M.,Boonyaratanakornkit, J.
Cross-protective antibodies against common endemic respiratory viruses.
Nat Commun, 14:798-798, 2023
Cited by
PubMed Abstract: Respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and human parainfluenza virus types one (HPIV1) and three (HPIV3) can cause severe disease and death in immunocompromised patients, the elderly, and those with underlying lung disease. A protective monoclonal antibody exists for RSV, but clinical use is limited to high-risk infant populations. Hence, therapeutic options for these viruses in vulnerable patient populations are currently limited. Here, we present the discovery, in vitro characterization, and in vivo efficacy testing of two cross-neutralizing monoclonal antibodies, one targeting both HPIV3 and HPIV1 and the other targeting both RSV and HMPV. The 3 × 1 antibody is capable of targeting multiple parainfluenza viruses; the MxR antibody shares features with other previously reported monoclonal antibodies that are capable of neutralizing both RSV and HMPV. We obtained structures using cryo-electron microscopy of these antibodies in complex with their antigens at 3.62 Å resolution for 3 × 1 bound to HPIV3 and at 2.24 Å for MxR bound to RSV, providing a structural basis for in vitro binding and neutralization. Together, a cocktail of 3 × 1 and MxR could have clinical utility in providing broad protection against four of the respiratory viruses that cause significant morbidity and mortality in at-risk individuals.
PubMed: 36781872
DOI: 10.1038/s41467-023-36459-3
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.62 Å)
構造検証レポート
Validation report summary of 8dg8
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon